BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 9667429)

  • 41. The influence of common stimulus parameters on distortion product otoacoustic emission fine structure.
    Johnson TA; Baranowski LG
    Ear Hear; 2012; 33(2):239-49. PubMed ID: 21918451
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of infrasound on cochlear damage from exposure to a 4 kHz octave band of noise.
    Harding GW; Bohne BA; Lee SC; Salt AN
    Hear Res; 2007 Mar; 225(1-2):128-38. PubMed ID: 17300889
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection and differentiation of sensorineural hearing loss in mice using auditory steady-state responses and transient auditory brainstem responses.
    Pauli-Magnus D; Hoch G; Strenzke N; Anderson S; Jentsch TJ; Moser T
    Neuroscience; 2007 Nov; 149(3):673-84. PubMed ID: 17869440
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Age-related changes in transiently evoked otoacoustic emissions and distortion product otoacoustic emissions in normal-hearing ears.
    Satoh Y; Kanzaki J; O-Uchi T; Yoshihara S
    Auris Nasus Larynx; 1998 May; 25(2):121-30. PubMed ID: 9673723
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of TEOAE and DPOAE measurements for the assessment of auditory thresholds in sensorineural hearing loss.
    Suckfüll M; Schneeweiss S; Dreher A; Schorn K
    Acta Otolaryngol; 1996 Jul; 116(4):528-33. PubMed ID: 8831837
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sex differences in distortion product otoacoustic emissions as a function of age in CBA mice.
    Guimaraes P; Zhu X; Cannon T; Kim S; Frisina RD
    Hear Res; 2004 Jun; 192(1-2):83-9. PubMed ID: 15157966
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Further efforts to predict pure-tone thresholds from distortion product otoacoustic emission input/output functions.
    Gorga MP; Neely ST; Dorn PA; Hoover BM
    J Acoust Soc Am; 2003 Jun; 113(6):3275-84. PubMed ID: 12822800
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An objective method of analyzing cochlear versus noncochlear patterns of distortion-product otoacoustic emissions in patients with acoustic neuromas.
    Telischi F
    Laryngoscope; 2000 Apr; 110(4):553-62. PubMed ID: 10763999
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alternative distortion product otoacoustic emissions and hearing loss in a clinical population.
    Lind O
    Scand Audiol; 1999; 28(4):257-61. PubMed ID: 10572971
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Distortion product otoacoustic emissions for hearing threshold estimation and differentiation between middle-ear and cochlear disorders in neonates.
    Janssen T; Gehr DD; Klein A; Müller J
    J Acoust Soc Am; 2005 May; 117(5):2969-79. PubMed ID: 15957767
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Myosin light chain kinase regulates hearing in mice by influencing the F-actin cytoskeleton of outer hair cells and cochleae.
    Yang X; Wang JG; Ma DB; Ma XF; Zhu GJ; Zhou H; Yu CJ; Qian XY; Gao X
    Int J Mol Med; 2014 Apr; 33(4):905-12. PubMed ID: 24481113
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Observations of Distortion Product Otoacoustic Emission Components in Adults With Hearing Loss.
    Prieve BA; Thomas L; Long G; Talmadge C
    Ear Hear; 2020; 41(3):652-662. PubMed ID: 31569117
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostics of the cochlear amplifier by means of distortion product otoacoustic emissions.
    Janssen T; Niedermeyer HP; Arnold W
    ORL J Otorhinolaryngol Relat Spec; 2006; 68(6):334-9. PubMed ID: 17065826
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical relevance of distortion product emissions by means of receiver operating characteristic (ROC) analysis.
    Steinhart HU; Bohlender JE; Benttzien S; Hoppe U
    Scand Audiol; 2001; 30(3):131-40. PubMed ID: 11683451
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Distortion product otoacoustic emission suppression tuning curves in normal-hearing and hearing-impaired human ears.
    Gorga MP; Neely ST; Dierking DM; Dorn PA; Hoover BM; Fitzpatrick DF
    J Acoust Soc Am; 2003 Jul; 114(1):263-78. PubMed ID: 12880040
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characteristic findings of auditory brainstem response and otoacoustic emission in the Bronx waltzer mouse.
    Inagaki M; Kon K; Suzuki S; Kobayashi N; Kaga M; Nanba E
    Brain Dev; 2006 Nov; 28(10):617-24. PubMed ID: 16730938
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of distortion-product and transient evoked otoacoustic emissions with ABR threshold shift in chinchillas with ototoxic damage.
    Kakigi A; Hirakawa H; Harel N; Mount RJ; Harrison RV
    Auris Nasus Larynx; 1998 Sep; 25(3):223-32. PubMed ID: 9799987
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Two-source interference as the major reason for auditory-threshold estimation error based on DPOAE input-output functions in normal-hearing subjects.
    Dalhoff E; Turcanu D; Vetešník A; Gummer AW
    Hear Res; 2013 Feb; 296():67-82. PubMed ID: 23268357
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Auditory neuropathy characteristics in children with cochlear nerve deficiency.
    Buchman CA; Roush PA; Teagle HF; Brown CJ; Zdanski CJ; Grose JH
    Ear Hear; 2006 Aug; 27(4):399-408. PubMed ID: 16825889
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of primary frequencies ratio on distortion product otoacoustic emissions amplitude. II. Interrelations between multicomponent DPOAEs, tone-burst-evoked OAEs, and spontaneous OAEs.
    Moulin A
    J Acoust Soc Am; 2000 Mar; 107(3):1471-86. PubMed ID: 10738802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.